EUVIMEDEUVIMED entdecken
Crossref

The Manchester Scoring System for predicting BRCA1/2 mutations underperforms in Arabic Omani breast cancer patients

Chantel van Wyk iD, Hasan Al-Sayegh, Sara I Al-Kiyumi, Ghaida S Al-Mamari, Abeer A Al Saegh

Journal of Genetic Counseling · 2025

DOI: 10.1002/jgc4.1939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Genetic Counseling, 2025. Verfasst von Chantel van Wyk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Department, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman. Hauptthemen laut MEDLINE: Breast Neoplasms, Mutation, BRCA1 Protein, BRCA2 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Risk assessment models that are applied to assess the lifetime risk of cancer and pathogenic variant risk are more commonly used in Western populations. Using these models, without validation, for non‐Western populations has been questioned. This study aimed to evaluate the use and consistency of the Manchester Scoring System as a risk assessment model for the Omani population. A retrospective, file‐based analysis was performed on breast cancer patients seen in a genomics department over a two‐year period. Personal cancer history and family history were used to analyze the Manchester scores of 409 breast and/or cancer patients. The results show that, overall, the Manchester scores were low. If this risk assessment model had been used to determine eligibility for a priori service and genetic testing decisions, 12 BRCA pathogenic cases would have been missed. At this time, the Manchester Scoring System does not seem to be the best risk assessment model for use in the Omani population, unless the eligibility threshold of ≥6 is used, which could provide a better sensitivity for the Omani population. We propose using concepts of the Manchester Scoring model to create a scoring system that is more suitable for the Omani and Arabic population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMutationBRCA1 ProteinBRCA2 ProteinHumansFemaleOmanRetrospective StudiesRisk AssessmentAdultMiddle AgedArabsGenetic Testing

Stichwörter der Autor:innen

BRCA1/2Arabic populationManchester Scoring Systemrisk assessmentsusceptibility testingunderrepresented populations

Substanzen

BRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • Genomics Department, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman.
  • Research Laboratories Department, Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Oman.

ORCID-Profile: Chantel van Wyk

Zitieren

APA

van Wyk, C., Al-Sayegh, H., Al-Kiyumi, S. I., Al-Mamari, G. S., & Al Saegh, A. A. (2025). The Manchester Scoring System for predicting BRCA1/2 mutations underperforms in Arabic Omani breast cancer patients. Journal of Genetic Counseling. https://doi.org/10.1002/jgc4.1939

Vancouver

van Wyk C, Al-Sayegh H, Al-Kiyumi SI, Al-Mamari GS, Al Saegh AA. The Manchester Scoring System for predicting BRCA1/2 mutations underperforms in Arabic Omani breast cancer patients. Journal of Genetic Counseling. 2025. doi:10.1002/jgc4.1939

BibTeX
@article{vanWyk2025,
  author = {van Wyk, Chantel and Al-Sayegh, Hasan and Al-Kiyumi, Sara I and Al-Mamari, Ghaida S and Al Saegh, Abeer A},
  title = {The Manchester Scoring System for predicting BRCA1/2 mutations underperforms in Arabic Omani breast cancer patients},
  journal = {Journal of Genetic Counseling},
  year = {2025},
  doi = {10.1002/jgc4.1939}
}
Kostenlos starten →